Friday, 19 April 2024
The growth of the market is driven by the factors such as increasing number of approvals for contrast agents and increasing number of patients suffering with chronic diseases. However, the market is likely to get affected due to side effects associated with the contrast media agents during the forecast period.
In an aging society where chronic diseases is a leading factor in the health system, technical advancements are necessary to preserve the quality of life through keeping the affordable prices. Chronic diseases can be defined as medical conditions that lasts for one year or more and requires ongoing medical attention or limit activities of daily living. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability that requires several imaging modalities for diagnostic and treatment monitoring purposes. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs.
Request For Sample Reports @ https://www.theinsightpartners.com/sample/TIPRE00003911/
Companies Mentioned
Additionally, there presence of robust products in the pipeline have been witnessed in the contrast media injectors market. For instance, Lantheus Medical Imaging, Inc., a US based medical imaging company actively involved in the commercialization of contrast media injectors and agents is undergoing clinical trials to develop Flurpiridaz F 18, a novel PET agent, with the first of two Phase 3 trials complete. Moreover, the company has also collaborated with academic centers in the U.S., Canada and the Europe to investigate fluorine-18-based positron emission tomography (PET) radiopharmaceutical imaging agent designed for molecular imaging of the norepinephrine pathway.
The US contrast media injectors market is segmented based on product and application. Among the product segment, the consumables segment is expected to grow at a significant rate of 7.7% during the forecast period. In addition, the segment is also anticipated to dominate the market by products during the year 2027, with a market share of around 65.0%
You Can Buy This Report from Here@ https://www.theinsightpartners.com/buy/TIPRE00003911/
US CONTRAST MEDIA INJECTORS– MARKET SEGMENTATION
By Product
US CONTRAST MEDIA INJECTORS – MARKET SEGMENTATION
By Application
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Smart Market News brings you the stories of adopting innovative solutions and strategies that have been changing the world. Our insights on products, solutions, companies, and adoption of best practices help in understanding the markets better and make smarter decisions.
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.
Buttermilk Powder Market Current and Future Trends, Growing Demand and Productio.. 
Aircraft Transparencies Market 2021: Material Capabilities Evaluation by Aeropai..